Paul R Mittelstadt1, Jesús M Salvador, Albert J Fornace
1Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. mittelsp@mail.nih.gov
Mitogen-activated protein kinases (MAPKs) use a cascade for activation. However, T cell receptor signaling activates p38 MAPK through a novel pathway, offering new therapeutic targets.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: